FAMILIAL CHYLOMICRONEMIA SYNDROME SECONDARY TO RARE DOUBLE HETEROZYGOUS MUTATIONS INVOLVING LPL AND APOA5 GENES

被引：0
|
作者：
Manam, Rupesh
Ueda, Masako
McIntyre, Adam D.
Hegele, Robert A.
Baum, Seth J.
机构：
来源：
CLINICAL CARDIOLOGY | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：6 / 6
页数：1
相关论文
共 27 条
  • [1] APOA5 Missense Mutations Associated with Chylomicronemia Sensitive to Fibrate Therapy
    Martinez, Alvaro
    Morineau, Gilles
    Dufernez, Fabienne
    Crie, Antoine
    Fruchart-Najib, Jamila
    Benlian, Pascale
    CIRCULATION, 2008, 118 (18) : S405 - S405
  • [2] NEW LPL AND APOA5 GEN MUTATIONS IDENTIFIED IN SUBJECTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    De Castro Oros, I.
    Garcia Otin, A. L.
    Pueyo, M.
    Mozas, P.
    Gomez, L.
    Fabiani, F.
    Alvarez-Sala, L.
    Ros, E.
    Zambon, D.
    Dalmau, J.
    Civeira, F.
    Pocovi, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 216 - 216
  • [3] Two novel mutations of the LPL gene in two Chinese family cases with familial chylomicronemia syndrome
    Wang, Mingying
    Zhou, Yuantao
    He, Xiaoli
    Deng, Chengjun
    Liu, Xiaoning
    Li, Juan
    Zhou, Lin
    Li, Ying
    Zhang, Yu
    Liu, Haifeng
    Li, Li
    CLINICA CHIMICA ACTA, 2021, 521 : 264 - 271
  • [4] Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes
    Koopal, Charlotte
    Bemelmans, Remy
    Marais, A. David
    Visseren, Frank L. J.
    BMJ CASE REPORTS, 2019, 12 (04)
  • [5] Rare APOA5 mutations -: Clinical consequences, metabolic and functional effects -: An ENID review
    Talmud, Philippa J.
    ATHEROSCLEROSIS, 2007, 194 (02) : 287 - 292
  • [6] The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits
    Webster, R. J.
    Warrington, N. M.
    Weedon, M. N.
    Hattersley, A. T.
    McCaskie, P. A.
    Beilby, J. P.
    Palmer, L. J.
    Frayling, T. M.
    DIABETOLOGIA, 2009, 52 (01) : 106 - 114
  • [7] The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits
    R. J. Webster
    N. M. Warrington
    M. N. Weedon
    A. T. Hattersley
    P. A. McCaskie
    J. P. Beilby
    L. J. Palmer
    T. M. Frayling
    Diabetologia, 2009, 52 : 106 - 114
  • [8] Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
    Surendran, R. P.
    Visser, M. E.
    Heemelaar, S.
    Wang, J.
    Peter, J.
    Defesche, J. C.
    Kuivenhoven, J. A.
    Hosseini, M.
    Peterfy, M.
    Kastelein, J. J. P.
    Johansen, C. T.
    Hegele, R. A.
    Stroes, E. S. G.
    Dallinga-Thie, G. M.
    JOURNAL OF INTERNAL MEDICINE, 2012, 272 (02) : 185 - 196
  • [9] Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel LPL Mutations by Whole-Exome Sequencing
    Liu, Ying
    Lan, Zhangzhang
    Zhao, Fang
    Zhang, Shuangchuan
    Zhang, Wenyong
    FRONTIERS IN GENETICS, 2020, 11
  • [10] Analysis of the influence of polymorphisms in the APOE, APOA5, LPL, LIPC and CETP genes on triglyceride levels in a working population in Malaga (Spain)
    Jose Ariza, Maria
    Maria Hornos, Ana
    Javier Baron, Francisco
    Calvo-Bonacho, Eva
    Rioja, Jose
    Valdivielso, Pedro
    Carlos Sainz-Gutierrez, Juan
    Ruiz-Moraga, Montserrat
    Antonio Gelpi, Jose
    Gonzalez-Santos, Pedro
    Angel Sanchez-Chaparro, Miguel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (02): : 62 - 71
123